Abstract:Sickle cell disease (SCD), a distinctive and often overlooked illness in the 21st century, is a congenital blood disorder characterized by considerable phenotypic diversity. It comprises a group of disorders, with sickle cell anemia (SCA) being the most prevalent and serious genotype. Although there have been some systematic reviews of global data, worldwide statistics regarding SCD prevalence, morbidity, and mortality remain scarce. In developed countries with a lower number of sickle cell patients, cutting-edge technologies have led to the development of new treatments. However, in developing settings where sickle cell disease (SCD) is more prevalent, medical management, rather than a cure, still relies on the use of hydroxyurea, blood transfusions, and analgesics. This is a disease that affects red blood cells, consequently affecting most organs in diverse manners. We discuss its etiology and the advent of new technologies, but the aim of this study is to understand the various types of nutrition-related studies involving individuals suffering from SCD, particularly in Africa. The interplay of the environment, food, gut microbiota, along with their respective genomes collectively known as the gut microbiome, and host metabolism is responsible for mediating host metabolic phenotypes and modulating gut microbiota. In addition, it serves the purpose of providing essential nutrients. Moreover, it engages in direct interactions with host homeostasis and the immune system, as well as indirect interactions via metabolites. Nutrition interventions and nutritional care are mechanisms for addressing increased nutrient expenditures and are important aspects of supportive management for patients with SCD. Underprivileged areas in Sub-Saharan Africa should be accompanied by efforts to define and promote of the nutritional aspects of SCD. Their importance is key to maintaining well-being and quality of life, especially because new technologies and products remain limited, while the use of native medicinal plant resources is acknowledged.

Sickle Cell Disease: From Genetics to Curative Approaches

Treating Sickle Cell Disease: Gene Therapy Approaches

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

Curative Therapies for Sickle Cell Disease

Current and Future Therapeutics for Treating Patients with Sickle Cell Disease

Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review

A critical review of therapeutic interventions in sickle cell disease: Progress and challenges

Current state of gene therapy in sickle cell disease

Gene Therapies for Sickle Cell Disease

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease

Therapeutics for sickle cell disease intravascular hemolysis

End Organ Affection in Sickle Cell Disease

Advancing life: innovative approaches to enhance survival in sickle cell anemia patients

Fostering a healthier generation of children with sickle cell disease through advancements in care

Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness

Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease

Sickle cell disease as a vascular disorder

Sickle Cell Disease: Current Drug Treatments and Functional Foods with Therapeutic Potential

Sickle Cell Disease in Brazil: Current Management

Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions

Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?